281 related articles for article (PubMed ID: 24745923)
1. Psoriasis and Vascular Risk : An Update.
Katsiki N; Anagnostis P; Athyros VG; Karagiannis A; Mikhailidis DP
Curr Pharm Des; 2014; 20(39):6114-25. PubMed ID: 24745923
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.
Tobin AM; Veale DJ; Fitzgerald O; Rogers S; Collins P; O'Shea D; Kirby B
J Rheumatol; 2010 Jul; 37(7):1386-94. PubMed ID: 20472927
[TBL] [Abstract][Full Text] [Related]
3. Cardiometabolic comorbidities and the approach to patients with psoriasis.
Gisondi P; Girolomoni G
Actas Dermosifiliogr; 2009 Dec; 100 Suppl 2():14-21. PubMed ID: 20096157
[TBL] [Abstract][Full Text] [Related]
4. [Psoriasis comorbidities].
Gkalpakiotis S
Cas Lek Cesk; 2017; 156(3):119-122. PubMed ID: 28722453
[TBL] [Abstract][Full Text] [Related]
5. Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community.
Menter A; Griffiths CE; Tebbey PW; Horn EJ; Sterry W;
J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1371-7. PubMed ID: 20384692
[TBL] [Abstract][Full Text] [Related]
6. The concept of psoriasis as a systemic inflammation: implications for disease management.
Reich K
J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():3-11. PubMed ID: 22356630
[TBL] [Abstract][Full Text] [Related]
7. Cardiac and cardiovascular morbidities in patients with psoriatic arthritis: a population-based case control study.
Kibari A; Cohen AD; Gazitt T; Bitterman H; Lavi I; Feldhamer I; Shalom G; Greenberg-Dotan S; Zisman D
Clin Rheumatol; 2019 Aug; 38(8):2069-2075. PubMed ID: 30937638
[TBL] [Abstract][Full Text] [Related]
8. Metabolic disorders in patients with psoriasis and psoriatic arthritis.
Mallbris L; Ritchlin CT; Ståhle M
Curr Rheumatol Rep; 2006 Oct; 8(5):355-63. PubMed ID: 16973109
[TBL] [Abstract][Full Text] [Related]
9. Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report.
Fan JM; Solomon DA; López GY; Hofmann JW; Colorado RA; Kim AS; Meisel K; Halabi C
BMC Neurol; 2020 Mar; 20(1):106. PubMed ID: 32199449
[TBL] [Abstract][Full Text] [Related]
10. Comorbidities in patients with psoriasis.
Gottlieb AB; Dann F
Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
[TBL] [Abstract][Full Text] [Related]
11. Metabolic comorbidities and psoriasis.
Gisondi P; Ferrazzi A; Girolomoni G
Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
Hu SC; Lan CE
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis: a skin disease associated with increased cardiovascular risk.
González-Gay MA; González-Vela C; González-Juanatey C
Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
[TBL] [Abstract][Full Text] [Related]
15. Research in practice: the systemic aspects of psoriasis.
Boehncke WH; Boehncke S
J Dtsch Dermatol Ges; 2008 Aug; 6(8):622-5. PubMed ID: 18564207
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis, the liver, and the gastrointestinal tract.
Gisondi P; Del Giglio M; Cozzi A; Girolomoni G
Dermatol Ther; 2010; 23(2):155-9. PubMed ID: 20415823
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
Boehncke WH; Boehncke S
G Ital Dermatol Venereol; 2008 Oct; 143(5):307-13. PubMed ID: 18833072
[TBL] [Abstract][Full Text] [Related]
18. Correlation of High-Density Lipoprotein-Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease.
Husni ME; Wilson Tang WH; Lucke M; Chandrasekharan UM; Brennan DM; Hazen SL
Arthritis Rheumatol; 2018 Aug; 70(8):1240-1250. PubMed ID: 29569857
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognosis in patients with psoriasis.
Gulliver W
Br J Dermatol; 2008 Aug; 159 Suppl 2():2-9. PubMed ID: 18700909
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis.
Shapiro J; Cohen AD; Weitzman D; Tal R; David M
J Am Acad Dermatol; 2012 Feb; 66(2):252-8. PubMed ID: 21742411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
